12:00 AM
 | 
May 14, 2012
 |  BC Week In Review  |  Clinical News  |  Clinical Results

SUN11031: Development discontinued

Daiichi Sankyo disclosed in its 4Q earnings for its fiscal year 2011 ending March 31, 2012, that it discontinued development of SUN11031. The product was in Phase III...

Read the full 120 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >